Tag: AMRX News


Amneal Pharmaceuticals Inc (NYSE: AMRX) Gets Approved for its Generic TobraDex

Amneal Pharmaceuticals Inc (NYSE: AMRX), a fully integrated pharma firm that concentrates on the distribution, manufacturing, and development of specialty and generic drug products, recently announced that it had managed to receive ANDA (Abbreviated New Drug Application) approval from the FDA for its generic TobraDex drug, which is the addition […]